A clinical trial of hyperalimentation in children with metastatic malignancies

✍ Scribed by Van Eys, J. ;Copeland, E. M. ;Cangir, A. ;Taylor, G. ;Teitell-Cohen, B. ;Carter, P. ;Ortiz, C.

• Publisher: John Wiley and Sons
• Year: 1980
• Tongue: English
• Weight: 777 KB
• Volume: 8
• Category: Article
• ISSN: 0098-1532
• DOI: 10.1002/mpo.2950080110

✦ Synopsis

Abstract

In a controlled, randomized prospective clinical trial the utility of intravenous hyperalimentation (IVH) in the administration of and tolerance to chemotherapy was tested. The conclusions reached were 1) IVH is safe with a tolerable infection rate; 2) infectious complications correlate significantly with the nutritional status of the patient, with the presence of IVH being only a secondary factor; 3) IVH may be used to rehabilitate patients nutritionally, even those on intensive chemoterhapy; 4) the ability to deliver chemotherapy to patients seems to be improved by IVH, especially in malnourished patients in a late stage of disease.